Mechanistic basis of Palbociclib combinatorial activity in ER+ breast cancer and nonbreast indications

Category Primary study
JournalCancer Research
Year 2016
This article has no abstract
Epistemonikos ID: 5be26b0f367ee2a59915b26c4831b23116ed0726
First added on: Feb 08, 2025